Fig. 4: A combination of tautomycin and enzalutamide inhibited ARV-positive 22RV1 cells proliferation. | Cell Death Discovery

Fig. 4: A combination of tautomycin and enzalutamide inhibited ARV-positive 22RV1 cells proliferation.

From: Tautomycin and enzalutamide combination yields synergistic effects on castration-resistant prostate cancer

Fig. 4

A The cell viability of 22RV1 was detected using MTT assay after treatment with indicated drugs. B Representative images of colony formation assay in 22RV1 cells treated with tautomycin and enzalutamide. C Representative images of EdU incorporation in 22RV1 cells treated with tautomycin and enzalutamide. Nuclei were stained with Hoechst 33342 (scale bars: 50 μm). #Synergy by bliss-independent analysis.

Back to article page